SCHEMBL2002884

SCHEMBL2002884

O=C(O)Cc1cn(Cc2ccc(O)cc2)c2cc(O)ccc12

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 1/20 0.56
ALDH1A1 P00352 1/20 0.55
LMNA P02545 1/20 0.55
PPARD Q03181 4/20 0.52
PPARG P37231 3/20 0.52
PPARA Q07869 3/20 0.52
SLC22A12 Q96S37 7/20 0.46
CHRNB2 P17787 1/20 0.46
CHRNA7 P36544 1/20 0.46
CHRNA4 P43681 1/20 0.46
CA2 P00918 1/20 0.45
CAMK2A Q9UQM7 1/20 0.45
PLA2G4A P47712 1/20 0.43
LCK P06239 1/20 0.42
FYN P06241 1/20 0.42
AKR1B1 P15121 1/20 0.42
GRB2 P62993 1/20 0.42
MCL1 Q07820 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2008137 0.93 PLA2G2A (0.65) PLA2G2AALDH1A1LMNAPPARDPPARG
SCHEMBL2009336 0.90 SLC22A12 (0.51) PLA2G2AALDH1A1LMNAPPARDPPARG
SCHEMBL2008743 0.89 PLA2G2A (0.70) PLA2G2AALDH1A1LMNAPPARDPPARG
SCHEMBL2003929 0.88 LMNA (0.61) PLA2G2AALDH1A1LMNAPPARDPPARG
SCHEMBL2012378 0.83 AKR1B1 (0.51) PLA2G2AALDH1A1LMNAPPARDPPARG
SCHEMBL2004159 0.82 PLA2G2A (0.81) PLA2G2AALDH1A1LMNAPPARDPPARG
SCHEMBL2008179 0.82 PLA2G2A (0.58) PLA2G2AALDH1A1LMNAPPARDPPARG
SCHEMBL13802400 0.79 PLA2G2A (0.61) PLA2G2AALDH1A1LMNAPPARDPPARG
SCHEMBL2007378 0.79 LMNA (0.57) PLA2G2AALDH1A1LMNAPPARDPPARG
SCHEMBL2005762 0.77 PLA2G2A (0.70) PLA2G2AALDH1A1LMNAPPARDPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8884020-B2 Indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2014-11-11 US disclosed
US-8884020-B2 Indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2014-11-11 US disclosed
EP-2610244-A1 Indole compounds Ironwood Pharmaceuticals, Inc. (US) 2013-07-03 EP disclosed
US-7960544-B2 Useful indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2011-06-14 US disclosed
US-7960544-B2 Useful indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2011-06-14 US disclosed
US-7960544-B2 Useful indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2011-06-14 US disclosed
US-20100197708-A1 INDOLE COMPOUNDS WELLS FARGO BANK, NATIONAL ASSOCIATION 2010-08-05 US disclosed
US-20100197708-A1 INDOLE COMPOUNDS WELLS FARGO BANK, NATIONAL ASSOCIATION 2010-08-05 US disclosed
US-20090264653-A1 USEFUL INDOLE COMPOUNDS IRONWOOD PHARMACEUTICALS, INC. 2009-10-22 US disclosed
US-20090264653-A1 USEFUL INDOLE COMPOUNDS IRONWOOD PHARMACEUTICALS, INC. 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197708-A1 INDOLE COMPOUNDS IDO1, IDO2, TPH2 PLA2G2A 3285/4885ALDH1A1 1229/4885LMNA 3450/4885
US-20090264653-A1 USEFUL INDOLE COMPOUNDS FAAH, FAAH2, AANAT PLA2G2A 326/4885ALDH1A1 178/4885LMNA 4536/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.